anyone have any input on Ocera's ability to fundraise this year to pay for the needed trials? I think there is a lot of potential here in the pipeline, and based on the recent presentation, however funding and dilution are definite headwinds. thoughts?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.